Join
Live feed
·
INSIDERFilingvia Quantisnow
Xeris Biopharma Holdings Inc. logo

Director Johnson John sold $91,422 worth of shares (15,000 units at $6.09) as part of a pre-agreed trading plan and was granted 24,193 shares, increasing direct ownership by 1% to 707,276 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XERS· Xeris Biopharma Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XERS (Xeris Biopharma Holdings Inc.) and more on Quantisnow.

Director Johnson John sold $91,422 worth of shares (15,000 units at $6.09) as part of a pre-agreed trading plan and was granted 24,193 shares, increasing direct ownership by 1% to 707,276 units (SEC Form 4) | Quantisnow